About this trial
This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
* Adults ≥ 18 years of age
Histopathologic or cytologic diagnosis of thoracic cancers, including lung and esophageal
Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
Ability to understand and the willingness to sign a written informed consent
Disqualifiers
Patients with cognitive disability unable to maintain 30-60 minute conversation
Trial population
Patients with thoracic cancers, including lung and esophageal, recruited through USC/Norris Comprehensive Cancer Center
Trial design
Cohort
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionNon-interventional study
Treatment groups
Trial outcomes
Primary outcomes
Thematic saturation
Will use a Danaher framework to approach analyze interview data using NVivo software (NVivo version 11.0, QSR International). Each interview will be analyzed to identify broad themes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Southern California
Lead sponsor
National Cancer Institute (NCI)
Collaborator